| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/05/2004 | US20040151754 Steroid suspensions for intraocular use |
| 08/05/2004 | US20040151710 Topical composition for treating infectious conditions of skin and mucosa |
| 08/05/2004 | US20040151692 administering a substance that can activate CD163 to stimulate the growth, proliferation, differentiation and/or mobilization of a stem cell, e.g., a substance that binds CD163 includes antibodies and CD163 ligands. |
| 08/05/2004 | US20040151688 Adhesive treatment for epistaxis |
| 08/05/2004 | US20040151671 Topical applying; pressurized container with alcohol foaming agents; acne therapy |
| 08/05/2004 | DE20220910U1 Zusammensetzungen zur Verhinderung des Missbrauchs von Opioiden Compositions to prevent the misuse of opioids |
| 08/05/2004 | DE10303672A1 Verwendung eines Neuropeptide und Steroide enthaltenden Gemisches zur Behandlung von Störungen des psychosozialen Erlebens und Verhaltens Use of a mixture containing neuropeptides and steroids for the treatment of disorders of psychosocial experience and behavior |
| 08/05/2004 | DE10261067A1 Cholesterinsenkendes Mittel, enthaltend eine n-3-Fettsäure Cholesterol-lowering agents containing an n-3 fatty acid |
| 08/05/2004 | CA2802143A1 Cancer therapy sensitizer |
| 08/05/2004 | CA2554012A1 Oral dosage formulation |
| 08/05/2004 | CA2553428A1 Pharmaceutical compositions and methods for treating multidrug resistant cancer |
| 08/05/2004 | CA2518888A1 Method for inhibition of necrosis induced by neurotrophin |
| 08/05/2004 | CA2513881A1 Immunomodulatory compositions |
| 08/05/2004 | CA2513675A1 Methods of identifying modulators of cellular glycosylation using gtrap3-18 |
| 08/05/2004 | CA2513432A1 Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist |
| 08/05/2004 | CA2513029A1 Intradermal cellular delivery using narrow gauge micro-cannula |
| 08/05/2004 | CA2512319A1 Compositions and methods for combination antiviral therapy |
| 08/04/2004 | EP1443108A2 Processes for preparing reconstructed skin supplemented in ceramid 7 and/or 5.5, composition based on lamellar lipid vesicles comprising a derivative of ceramid 7 and/or 5.5 and use thereof |
| 08/04/2004 | EP1442747A1 Superoxide dismutase and mimetics thereof |
| 08/04/2004 | EP1442745A1 Orally administrable opioid formulations having extended duration of effect |
| 08/04/2004 | EP1442744A2 Use of EP4 receptor ligands in the treatment of, inter alia, neuropathic pain and colon cancer |
| 08/04/2004 | EP1442743A1 Medicament comprising alpha-lipoic acid, ambroxol and/or inhibitors of the angiotensin converting enzyme (ACE) for use in the treatment of neurodegenerative diseases |
| 08/04/2004 | EP1442132A2 Methods for the treatment of osteoarthritis and compositions thereof |
| 08/04/2004 | EP1442064A2 Kinases and phosphatases |
| 08/04/2004 | EP1442062A2 Methods for the treatment of carcinoma |
| 08/04/2004 | EP1442060A2 A novel g protein-coupled receptor, gave 10 |
| 08/04/2004 | EP1442042A1 Polycyclic guanine derivative phosphodiesterase v inhibitors |
| 08/04/2004 | EP1442037A1 Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands |
| 08/04/2004 | EP1442036A2 Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1 |
| 08/04/2004 | EP1442028A1 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 08/04/2004 | EP1441772A2 Polymer conjugates of protein kinase c inhibitors |
| 08/04/2004 | EP1441770A1 Vaginally administerd anti-dysrhythmic agents for treating pelvic pain and infertility |
| 08/04/2004 | EP1441766A2 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof |
| 08/04/2004 | EP1441751A1 TARGETING THE REVERSE MODE OF THE Na+ /Ca2+ EXCHANGER FOR THE TREATMENT OF OPTIC NEUROPATHY ASSOCIATED WITH GLAUCOMA AND ISCHEMIC OPTIC NEUROPATHY |
| 08/04/2004 | EP1441743A2 Methods for treating ocular neovascular diseases |
| 08/04/2004 | EP1441742A2 Axon repair |
| 08/04/2004 | EP1441734A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
| 08/04/2004 | EP1441733A1 Pharmaceutical compositions for the treatment of leukemia comprising dioxolane nucleosides analogs |
| 08/04/2004 | EP1441730A1 Hydrazono-malonitriles |
| 08/04/2004 | EP1441724A1 Methods of increasing endogenous testosterone levels |
| 08/04/2004 | EP1441723A1 Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension |
| 08/04/2004 | EP1441722A2 Modulators of kcnq potassium channels and use thereof in treating migraine and mechanistically related diseases |
| 08/04/2004 | EP1441720A1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system |
| 08/04/2004 | EP1441717A1 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog |
| 08/04/2004 | EP1441714A2 Combinations comprising a selective cyclooxygenase-2 inhibitor |
| 08/04/2004 | EP1441710A1 Use of n,n-diethyl-2- -4-(phenylmethyl)-phenoxy ethanamine monohydrochloride (dppe) in cancer therapy |
| 08/04/2004 | EP1441708A1 Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
| 08/04/2004 | EP1441707A1 Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder |
| 08/04/2004 | EP1441705A1 Solid, stabilized, prompt- and/or modified-release therapeutical systems for the oral administration of liquid active principles, excipients or foodstuffs |
| 08/04/2004 | EP1441702A2 Method for treating primary insomnia |
| 08/04/2004 | EP1441694A1 Gastric raft composition |
| 08/04/2004 | EP1441689A1 Solid oral compositions |
| 08/04/2004 | EP1441685A2 Anti-irritating rosacea treatment |
| 08/04/2004 | EP1441684A2 Methods and compositions for treating urological disorders using 313, 333, 5464, 18817 or 33524 |
| 08/04/2004 | EP1441591A2 Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response |
| 08/04/2004 | EP1337236B1 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition |
| 08/04/2004 | EP1313772B1 New cross-linked derivatives of hyaluronic acid |
| 08/04/2004 | EP1296675B1 Compositions based on aminoacids, suitable for the treatment of heart failure |
| 08/04/2004 | EP1202730B1 Use of ep4 receptor ligands in the treatment of neuropathic pain |
| 08/04/2004 | EP1196155B1 New use of compounds as antibacterial agents |
| 08/04/2004 | EP1171151A4 Thrombospondin-2 and uses thereof |
| 08/04/2004 | EP1169054B1 Prognosis of ptp lar related diseases |
| 08/04/2004 | EP1150658B1 Method for controlling liposome size |
| 08/04/2004 | EP1129212B1 Screening process for antibacterial agents |
| 08/04/2004 | EP1034001B1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome |
| 08/04/2004 | EP0950059B1 Cyclic sulfone derivatives |
| 08/04/2004 | EP0934531B1 Diagnosis of spongiform encephalopathy |
| 08/04/2004 | CN1518604A Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto |
| 08/04/2004 | CN1518553A Beta-substituted befa-aminoethyl. phosphonates compound |
| 08/04/2004 | CN1518543A Pyrazole derivatives and their use as protein kinase inhibitors |
| 08/04/2004 | CN1518461A Medicinal compositions |
| 08/04/2004 | CN1518460A Composition comprising PDE-4 inhibitor and H1-receptor antagonist and use thereof for manufacture of medicament for treatment of respiratory diseases |
| 08/04/2004 | CN1518458A Graft rejection inhibitors |
| 08/04/2004 | CN1518455A Anti-bacterial agent |
| 08/04/2004 | CN1518445A Treatment of sexual dysfunction |
| 08/04/2004 | CN1160371C NOTCH protein and their ligands |
| 08/04/2004 | CN1160115C Irrigation solution and method for inhibition of pain, inflammation and spasm |
| 08/04/2004 | CN1160068C Inihibition of lipoprotein oxidation |
| 08/04/2004 | CN1160065C Use of preparing medicine for treating depression by low affinity NMDA antagonists |
| 08/04/2004 | CN1160057C Microemlusions used as carriers for administration of active compounds |
| 08/03/2004 | US6770797 Inducing prolonged in vivo gene expression in a mammal for inhibiting alzheimer's disease associated neuronal cell death |
| 08/03/2004 | US6770778 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 08/03/2004 | US6770743 Genetic engineered drug |
| 08/03/2004 | US6770742 Use of inhibitors for the treatment of disorders related to RTK hyperfunction, especially cancer |
| 08/03/2004 | US6770673 Administering dimethylaminoarglabin or salt as antitumor agent |
| 08/03/2004 | US6770666 Fused-ring compounds and use thereof as drugs |
| 08/03/2004 | US6770655 2-imidazomethyl- pyrido(4,3-b)indol-1-one or -carbazol-1-one derivatives containing an ester group; especially for treating irritable bowel syndrome. |
| 08/03/2004 | US6770632 Folypolyglutamyl synthetase gene transfer to enhance antifolate |
| 08/03/2004 | US6770628 Hematopoietic stimulation |
| 08/03/2004 | US6770620 Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders |
| 08/03/2004 | US6770619 Lung surfactant compositions with dynamic swelling behavior |
| 08/03/2004 | US6770456 Endogenous retrovirus tumor associated nucleic acids and antigens |
| 08/03/2004 | US6770449 Methods of assaying receptor activity and constructs useful in such methods |
| 08/03/2004 | US6770305 Oral administration to counteract dehydration resulting from vomiting, diarrhea, physical exercise or illness; especially suitable for infants, small children and the elderly; water, sodium, potassium, citrate, carbonate and structuring |
| 08/03/2004 | US6770282 Purified nucleic acid molecule encoding rabies glycoprotein g, complexed with a cationic lipid comprising tetramethyltetraalkyl spermine analog lipid; enhances immune response compared to administration of a naked dna vaccine |
| 08/03/2004 | US6770267 Methods of treating periodontal disease |
| 08/03/2004 | US6770263 Compositions and methods for the treatment of aches and pains |
| 08/03/2004 | US6770262 Intranasally administering metoclopramide or its salt for therapy or reducing the symptoms of gastroparesis in a patient |
| 08/03/2004 | US6770260 Mammal model contains a decreased level of endogenous macrophages sufficient to reduce depletion of non-autologous hematopoietic cells, achieved by administering an effective amount of dichloromethylene diphosphonate |
| 08/03/2004 | CA2058768C Treatment and control of ocular development |